NYSE: CLBCore Laboratories Inc Stock
$12.07-0.37 (-2.97%)
Updated Apr 23, 2025
CLB Price
$12.07
Fair Value Price
N/A
Market Cap
$565.20M
52 Week Low
$10.15
52 Week High
$25.13
P/E
17.49x
P/B
2.24x
P/S
1.55x
PEG
1.02x
Dividend Yield
0.33%
Revenue
$523.85M
Earnings
$31.40M
Gross Margin
19.7%
Operating Margin
11.03%
Profit Margin
6%
Debt to Equity
1.32
Operating Cash Flow
$56M
Beta
1.29
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CLB Overview
Core Laboratories N.V. provides core and fluid analysis to the oil and gas industry to increase production from its clients' reservoirs. Specialties include basic rock properties, core analysis, and PVT characterization of reservoir fluids. Analytical and field services characterize the properties of crude oil and integrated diagnostic services evaluate the effectiveness of well completions. Core Laboratories was founded in 1936 and is based in Amstelveen, the Netherlands.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CLB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil & Gas Equipment & Service
Industry Rating
B
CLB
Ranked#39 of 49
Ranked#39 of 49
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.17 | A | |
| $29.21 | A | |
| $6.79 | A |
Be the first to know about important CLB news, forecast changes, insider trades & much more!
CLB News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CLB ($12.07) is trading above its intrinsic value of $7.74, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLB is good value based on its earnings relative to its share price (17.49x), compared to the US market average (26.95x)
P/E vs Market Valuation
CLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CLB due diligence checks available for Premium users.
Valuation
CLB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.49x
Industry
15.08x
Market
26.95x
CLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CLB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.24x
Industry
1.87x
CLB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CLB price to earnings growth (PEG)
For valuing profitable companies with growth potential
CLB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CLB's financial health
Profit margin
Revenue
$129.2M
Net Income
$7.4M
Profit Margin
5.7%
CLB's Earnings (EBIT) of $57.80M... subscribe to Premium to read more.
Interest Coverage Financials
CLB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$590.4M
Liabilities
$332.7M
Debt to equity
1.32
CLB's short-term assets ($226.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLB's long-term liabilities ($235.08M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$20.6M
Investing
-$3.6M
Financing
-$19.4M
CLB's operating cash flow ($56.39M)... subscribe to Premium to read more.
Debt Coverage Financials
CLB vs Oil & Gas Equipment & Service Stocks
Core Laboratories Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.